Veru is an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer and breast cancer. Management Team Mitchell Steiner, M.D., F.A.C.S. – Chairman, President, and Chief Executive Officer Harry Fisch, M.D., F.A.C.S. – Vice Chairman, Chief Corporate Officer Michele Greco – Chief Financial Officer and Chief Administrative Officer K. Gary Barnette, Ph.D. – Chief Scientific Officer Gary Bird, Ph.D. – Senior Vice President – Quality Oversight Samuel Fisch – Director, Investor Relations Robert H. Getzenberg, Ph.D. – Executive Vice President for Medical Affairs Kevin Gilbert, JD, CPA – Executive Vice President Corporate Development Philip Greenberg – Executive Vice President Legal, Secretary Phillip Kuhn – Executive Vice President – Strategy & Commercial Michael J. Purvis – Executive Vice President, General Counsel & Corporate Strategy Domingo Rodriguez, M.D. – Executive Vice President of Clinical Operations Board of Directors Mitchell S. Steiner, M.D., F.A.C.S. – Chairman, President, and Chief Executive Officer Harry Fisch, M.D., F.A.C.S. – Vice Chairman Mario Eisenberger, M.D. Grace S. Hyun, M.D. Lucy Lu, M.D. Michael L. Rankowitz MIAMI | LONDON | MALAYSIA © 2021 Veru Inc. | All Rights Reserved | Accreditation and Certificates | Privacy Policy | Anti-Trafficking Policy | Terms of Use | Contact Us Website Design by Get Sharp, Inc.